In addition, we also showed that a high expression of COX‐2 in CAF was positively correlated with relapse (P = .02) and poor survival (P = .034) in patients with NPC, suggesting that the high expression of COX‐2 in CAF confers poor outcome in NPC (Table 1). This evidence concerns the gene PTGS2 and nasopharyngeal carcinoma.